Sanofi Pasteur Influenza Vaccines

[Pages:3]SAU S.SFL U .1 9 .0 5 .2 9 8 5

Sanofi Pasteur Influenza Vaccines

Chris Whitman

Our Credo

Sanofi Pasteur believes in a world in which no one suffers or dies from a

vaccine-preventable disease.

SAU S.SFL U .1 9 .0 5 .2 9 8 5

5/19 2

2019 National Adult and Influenza Immunization Summit ? 5/16/2019

1

We Are Focused on Helping to Prevent as Much Influenza Disease As Possible

? Change the influenza conversation from infection to influenza disease and its outcomes

Vaccinate As Many People as Possible

? Increase public awareness of the real impact of flu and the value of flu vaccines

Deliver the Highest Quality Vaccine(s)

Possible

? Grow availability and use of vaccines proven to prevent more disease in higher-risk populations

? Invest in better understanding the impact of current vaccines and development of improved solutions

SAU S.SFL U .1 9 .0 5 .2 9 8 5

5/19 3

Communications Around Influenza Require the Urgency and Assertiveness Given to Heart Disease and Diabetes

SAU S.SFL U .1 9 .0 5 .2 9 8 5

2019 National Adult and Influenza Immunization Summit ? 5/16/2019

5/19 4

2

Sanofi Pasteur's Legacy Of Innovating and Investing Continues

? 2018?19 Season: Delivered nearly 70 million doses to the US

? 22M Fluzone? High-Dose (Influenza Vaccine), representing nearly 2/3 of immunizations in the targeted population

? 12X increase in Flublok? Quadrivalent (Influenza Vaccine) distribution ? Fluzone? Quadrivalent (Influenza Vaccine) remains the most used influenza vaccine brand

? 2019?20 Season: Producing 70 million doses to help protect Americans of all ages

? 10th year of growth for Fluzone High-Dose demand ? Flublok Quadrivalent growth continues

SAU S.SFL U .1 9 .0 5 .2 9 8 5

5/19 5

2019 National Adult and Influenza Immunization Summit ? 5/16/2019

3

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download